Literature DB >> 24216445

Sorafenib efficacy for treatment of HCC recurrence after liver transplantation is an open issue.

Andrea Mancuso1, Chiara Mazzarelli2, Giovanni Perricone2, Claudio Zavaglia2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24216445     DOI： 10.1016/j.jhep.2013.10.030

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  6 in total

Review 1.  Managements of recurrent hepatocellular carcinoma after liver transplantation: A systematic review.

Authors:  Nicola de'Angelis; Filippo Landi; Maria Clotilde Carra; Daniel Azoulay
Journal:  World J Gastroenterol       Date:  2015-10-21       Impact factor: 5.742

Review 2.  Care of the liver transplant patient.

Authors:  Mamatha Bhat; Said Al-Busafi; Marc Deschênes; Peter Ghali
Journal:  Can J Gastroenterol Hepatol       Date:  2014-04

Review 3.  Hepatocellular carcinoma: A comprehensive review.

Authors:  Lisa P Waller; Vrushak Deshpande; Nikolaos Pyrsopoulos
Journal:  World J Hepatol       Date:  2015-11-18

Review 4.  Hepatocellular Carcinoma and Liver Transplantation: State of the Art.

Authors:  Andrea Mancuso; Giovanni Perricone
Journal:  J Clin Transl Hepatol       Date:  2014-09-15

5.  Antitumoral effect of Ocoxin in hepatocellular carcinoma.

Authors:  Elena Díaz-Rodríguez; Al-Mahy El-Mallah; Eduardo Sanz; Atanasio Pandiella
Journal:  Oncol Lett       Date:  2017-06-21       Impact factor: 2.967

6.  Identification of glypican-3-derived long peptides activating both CD8+ and CD4+ T cells; prolonged overall survival in cancer patients with Th cell response.

Authors:  Mohammad A Sayem; Yusuke Tomita; Akira Yuno; Masatoshi Hirayama; Atsushi Irie; Hirotake Tsukamoto; Satoru Senju; Eiji Yuba; Toshiaki Yoshikawa; Kenji Kono; Tetsuya Nakatsura; Yasuharu Nishimura
Journal:  Oncoimmunology       Date:  2015-08-31       Impact factor: 8.110
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.